TCAF
T Rowe Price Capital Appreciation Equity ETF

39
Loading...
Loading...
News
all
press releases
News Placeholder
Why Did BioNTech Stock Surge 10% Pre-Market Today?
DualityBio now plans to discuss the next steps with the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA) of China regarding the submission of an application for Trastuzumab Pamirtecan approval.
Stocktwits·22d ago
News Placeholder
Ascendis Pharma Eyes Best Open In A Month After Q4 Print, But BofA Cuts Price Target: Retail Gets Buzzing
The brokerage adjusted its 2025 Yorvipath sales forecast downward, expecting a more backloaded ramp.
Stocktwits·8mo ago
News Placeholder
T. ROWE PRICE CAPITAL APPRECIATION FUND ESTABLISHES NEW RECORD FOR PERFORMANCE CONSISTENCY
T. ROWE PRICE CAPITAL APPRECIATION FUND ESTABLISHES NEW RECORD FOR PERFORMANCE CONSISTENCY T. ROWE PRICE CAPITAL APPRECIATION FUND ESTABLISHES NEW RECORD FOR PERFORMANCE CONSISTENCY PR Newswire...
PR Newswire·9mo ago

Latest TCAF News

View

Advertisement|Remove ads.

Advertisement|Remove ads.